《Journal Of Hepatocellular Carcinoma》雜志的最新年發(fā)文量為171篇。
這表明該刊在每年都會精選并發(fā)表一定數(shù)量的高質量文章，以保持其在腫瘤學領域的學術影響力。
該刊聚焦于醫(yī)學-腫瘤學領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發(fā)表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 16 Weeks 。
Journal Of Hepatocellular Carcinoma 雜志發(fā)文統(tǒng)計
文章名稱引用次數(shù)
- Role of Wnt/beta-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance28
- Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions20
- Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date15
- LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance13
- Pretreatment neutrophil-lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma11
- Hepatocellular carcinoma: a review of diagnostic challenges for the pathologist9
- Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives8
- Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine8
- Intermediate stage hepatocellular carcinoma: a summary review7
- Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With Wolves5
國家/地區(qū)發(fā)文量
- USA25
- CHINA MAINLAND20
- Egypt4
- England4
- Spain4
- Italy3
- Brazil2
- France2
- South Korea2
- Taiwan2
